SynbiCITE

Last updated

SynbiCITE
Formation2013 (2013)
Type Business Incubator
PurposeSupporting synthetic biology in industry
Headquarters Imperial College London
Affiliations Innovate UK, EPSRC, BBSRC
Website SynbiCITE.com

SynbiCITE is the UK's national Innovation and Knowledge Centre (IKC) for the adoption and use of synthetic biology by industry. [1] It also helps to incubate new businesses by providing them with space and accelerator programs, including funding, training and mentoring.

Contents

History

SynbiCITE was created in 2013 after a UK-wide competition to find the most suitable host university with the best strategic plan. [2] Initially funded by the government and other partners for five years, the organization was intended to become self-sustaining by 2018. [3] [4] In April 2016, SynbiCITE opened the Synthetic Biology Foundry, a Research Councils UK-funded facility providing remote gene design, construction, and validation services using laboratory robotics. Based on a similar facility at MIT, it is the first commercial facility in the United Kingdom using laboratory automation to provide on-demand services specifically for synthetic biology. [5] [6]

In 2019, the DNA Foundry opened at Imperial College London's White City Campus. [7] Its goal is to enable businesses to outsource DNA manufacture, design, and testing and accelerate the development of DNA-based technologies in the UK. SynbiCITE also supported the development of OpenCell, which provides affordable biotechnology labs using shipping containers in White City. [8]

Organisation

SynbiCITE is headquartered at Imperial College London. It is funded by a public-private partnership between the EPSRC, BBSRC, and Innovate UK, as well as several industrial and private investors. [9] It is run and managed by a board consisting of two co-directors (Professor Richard Kitney and Professor Paul Freemont).

Related Research Articles

<span class="mw-page-title-main">Michael Smith (chemist)</span> British-born Canadian biochemist, businessman and Nobel Prize laureate (1932–2000)

Michael Smith was a British-born Canadian biochemist and businessman. He shared the 1993 Nobel Prize in Chemistry with Kary Mullis for his work in developing site-directed mutagenesis. Following a PhD in 1956 from the University of Manchester, he undertook postdoctoral research with Har Gobind Khorana at the British Columbia Research Council in Vancouver, British Columbia, Canada. Subsequently, Smith worked at the Fisheries Research Board of Canada Laboratory in Vancouver before being appointed a professor of biochemistry in the UBC Faculty of Medicine in 1966. Smith's career included roles as the founding director of the UBC Biotechnology Laboratory and the founding scientific leader of the Protein Engineering Network of Centres of Excellence (PENCE). In 1996 he was named Peter Wall Distinguished Professor of Biotechnology. Subsequently, he became the founding director of the Genome Sequencing Centre at the BC Cancer Research Centre.

<span class="mw-page-title-main">Medical Research Council (United Kingdom)</span> National medical research agency

The Medical Research Council (MRC) is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation (UKRI), which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.

E-Science or eScience is computationally intensive science that is carried out in highly distributed network environments, or science that uses immense data sets that require grid computing; the term sometimes includes technologies that enable distributed collaboration, such as the Access Grid. The term was created by John Taylor, the Director General of the United Kingdom's Office of Science and Technology in 1999 and was used to describe a large funding initiative starting in November 2000. E-science has been more broadly interpreted since then, as "the application of computer technology to the undertaking of modern scientific investigation, including the preparation, experimentation, data collection, results dissemination, and long-term storage and accessibility of all materials generated through the scientific process. These may include data modeling and analysis, electronic/digitized laboratory notebooks, raw and fitted data sets, manuscript production and draft versions, pre-prints, and print and/or electronic publications." In 2014, IEEE eScience Conference Series condensed the definition to "eScience promotes innovation in collaborative, computationally- or data-intensive research across all disciplines, throughout the research lifecycle" in one of the working definitions used by the organizers. E-science encompasses "what is often referred to as big data [which] has revolutionized science... [such as] the Large Hadron Collider (LHC) at CERN... [that] generates around 780 terabytes per year... highly data intensive modern fields of science...that generate large amounts of E-science data include: computational biology, bioinformatics, genomics" and the human digital footprint for the social sciences.

The Engineering and Physical Sciences Research Council (EPSRC) is a British Research Council that provides government funding for grants to undertake research and postgraduate degrees in engineering and the physical sciences, mainly to universities in the United Kingdom. EPSRC research areas include mathematics, physics, chemistry, artificial intelligence and computer science, but exclude particle physics, nuclear physics, space science and astronomy. Since 2018 it has been part of UK Research and Innovation, which is funded through the Department for Business, Energy and Industrial Strategy.

<span class="mw-page-title-main">London Research Institute</span> Biological research facility

The Cancer Research UK London Research Institute (LRI) was a biological research facility which conducted research into the basic biology of cancer.

<span class="mw-page-title-main">Stephen Muggleton</span> Artificial intelligence researcher

Stephen H. Muggleton FBCS, FIET, FAAAI, FECCAI, FSB, FREng is Professor of Machine Learning and Head of the Computational Bioinformatics Laboratory at Imperial College London.

Expenditures by Canadian universities on scientific research and development accounted for about 40% of all spending on scientific research and development in Canada in 2006.

<span class="mw-page-title-main">Robert Mair, Baron Mair</span>

Robert James Mair, Baron Mair, is a geotechnical engineer and Emeritus Sir Kirby Laing Professor of Civil Engineering and director of research at the University of Cambridge. He is Head of the Cambridge Centre for Smart Infrastructure and Construction (CSIC). He was Master of Jesus College, Cambridge, from 2001 to 2011 and a fellow of St John's College, Cambridge, from 1998 to 2001. In 2014 he was elected a vice president of the Institution of Civil Engineers and on 1 November 2017 became the Institution's president for 2017–18, its 200th anniversary year. He was appointed an independent crossbencher in the House of Lords in 2015 and is currently a member of its Select Committee on Science and Technology.

<span class="mw-page-title-main">David Gann</span>

David Michael Gann CBE is a British academic administrator and civil engineer. He is Vice-President (Innovation) at Imperial College London and a member of the College's Executive Board. His academic research spans strategy, management science and systems engineering.

London Knowledge Lab was a research centre in Bloomsbury, London. It was founded in 2004 as a collaboration between the Institute of Education and Birkbeck, University of London. It was an interdisciplinary research centre, bringing together over 50 researchers from both social sciences and computer science backgrounds. The Institute of Education and Birkbeck announced the end of their collaboration in February 2016. Both institutions are continuing the work in their own separate Knowledge Lab research centres.

Do-it-yourself biology is a biotechnological social movement in which individuals, communities, and small organizations study biology and life science using the same methods as traditional research institutions. DIY biology is primarily undertaken by individuals with limited research training from academia or corporations, who then mentor and oversee other DIY biologists with little or no formal training. This may be done as a hobby, as a not-for-profit endeavor for community learning and open-science innovation, or for profit, to start a business.

<span class="mw-page-title-main">Francis Crick Institute</span> Biomedical research centre in London

The Francis Crick Institute is a biomedical research centre in London, which was established in 2010 and opened in 2016. The institute is a partnership between Cancer Research UK, Imperial College London, King's College London (KCL), the Medical Research Council, University College London (UCL) and the Wellcome Trust. The institute has 1,500 staff, including 1,250 scientists, and an annual budget of over £100 million, making it the biggest single biomedical laboratory in Europe.

<span class="mw-page-title-main">Laurence Pearl</span>

Laurence Harris Pearl FRS FMedSci is a British biochemist and structural biologist who is currently Professor of Structural Biology in the Genome Damage and Stability Centre and was Head of the School of Life Sciences at the University of Sussex.

<span class="mw-page-title-main">Department of Chemistry, Imperial College London</span>

The Department of Chemistry is responsible for chemistry teaching and research at Imperial College London. The department is one of the largest in the UK with around 63 academic staff, 10 teaching fellows, 95 postdoctoral research scientists and research fellows and 1150 students, including 240 PhD students,150 MRes students and around 750 students studying undergraduate courses. This community is further supported by over 45 support and administrative staff. The department is based across two sites.

<span class="mw-page-title-main">Nigel Scrutton</span>

Nigel Shaun Scrutton is a British biochemist and biotechnology innovator known for his work on enzyme catalysis, biophysics and synthetic biology. He is Director of the UK Future Biomanufacturing Research Hub, Director of the Fine and Speciality Chemicals Synthetic Biology Research Centre (SYNBIOCHEM), and Co-founder, Director and Chief Scientific Officer of the 'fuels-from-biology' company C3 Biotechnologies Ltd. He is Professor of Enzymology and Biophysical Chemistry in the Department of Chemistry at the University of Manchester. He is former Director of the Manchester Institute of Biotechnology (MIB).

<span class="mw-page-title-main">Henry Royce Institute</span> UK national institute for materials research

The Henry Royce Institute is the UK’s national institute for advanced materials research and innovation. Its vision is to identify challenges and to stimulate innovation in advanced materials research to support sustainable growth and development. Royce aims to be a "single front door" to the UK’s materials research community. Its stated mission is to “support world-recognised excellence in UK materials research, accelerating commercial exploitation of innovations, and delivering positive economic and societal impact for the UK.”

Susan RosserFRSB FLSW is a professor of Synthetic Biology at the University of Edinburgh.

<span class="mw-page-title-main">Florence Gschwend</span> Swiss chemical engineer

Florence Gschwend is a Swiss chemical engineer and Royal Academy of Engineering Enterprise Fellow at Imperial College London. She is the founder and CEO of Lixea, a spin-out company that commercialises wood fractionation to enable a circular bioeconomy.

The Rosalind Franklin Institute is medical research centre supported by the Government of the United Kingdom located at the Harwell Science and Innovation Campus, Oxfordshire, England. It is named after an English chemist Rosalind Franklin, whose discoveries provided the key data for the correct explanation of the helical structure of DNA in 1953. Launched on 6 June 2018, it was officially opened on 29 September 2021.

The Vaccines Manufacturing and Innovation Centre (VMIC) is a vaccine research and manufacturing facility under construction in Harwell Science and Innovation Campus in Oxfordshire, England. Announced in December 2018 and originally planned to be opened in 2022, its planned opening date has been brought forward to 2021 as a response to the COVID-19 pandemic.

References

  1. "Innovation and knowledge centres – EPSRC website". epsrc.ukri.org.
  2. "National hub to support synthetic biology extended with £5.5m funding commitment | Imperial News | Imperial College London". Imperial News. Retrieved 6 April 2023.
  3. "New Innovation and Knowledge Centre to drive UK's Synthetic Biology progress – EPSRC website".
  4. "News in brief – 18 July 2013". 17 July 2013.
  5. "The UK's First Robotic DNA Factory Has Opened in London".
  6. "'DNA factory' opens at Imperial College London" . Independent.co.uk . 6 April 2016. Archived from the original on 26 May 2022.
  7. "Behind-the-scenes @ London DNA Foundry, Imperial West White City". Friends of Imperial.
  8. Ireland, Tom (25 August 2018). "Buildings made from fungi? Meet London's pop-up bio-lab innovators".
  9. "UK's synthetic biology industry gets £10m boost – E & T Magazine".

51°29′58″N0°10′32″W / 51.49944°N 0.17556°W / 51.49944; -0.17556